Back to Search
PHILIP STIFF, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1194792143Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
35-04-1672(OH)
Research & Publications (20)
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
PMID 19307510·J Clin Oncol·2009
3-trial
Managing hematopoietic stem-cell transplant resources: the case for outpatient transplantation.
PMID 19172494·Leuk Lymphoma·2009
8-other
Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.
PMID 19167685·Biol Blood Marrow Transplant·2009
3-trial
c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.
PMID 19372257·Blood·2009
7-preclinical
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
PMID 19363221·Blood·2009
3-trial
Inverse relationship between dendritic cell CCR9 expression and maturation state.
PMID 19604301·Immunology·2009
7-preclinical
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.
PMID 19539214·Biol Blood Marrow Transplant·2009
3-trial
Allogeneic hematopoietic cell transplantation for metastatic breast cancer.
PMID 18084340·Bone Marrow Transplant·2008
3-trial
Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.
PMID 18246113·Bone Marrow Transplant·2008
4-observational
Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia.
PMID 18981008·Clin Cancer Res·2008
3-trial
Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial.
PMID 19021057·Leuk Lymphoma·2008
3-trial
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.
PMID 18645482·Transplantation·2008
3-trial
Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT.
PMID 18711352·Bone Marrow Transplant·2008
3-trial
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma.
PMID 17470451·Ann Oncol·2007
3-trial
Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
PMID 17580258·Biol Blood Marrow Transplant·2007
4-observational
Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity.
PMID 17365261·J Dermatolog Treat·2007
4-observational
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma.
PMID 17448919·Biol Blood Marrow Transplant·2007
3-trial
Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche.
PMID 17164824·Bone Marrow Transplant·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3949 SUNFOREST CT, SUITE 204
TOLEDO, OH 43623 - Phone
- (419) 292-0839
Quick Facts
- NPI
- 1194792143
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile